PNV 4.74% $2.43 polynovo limited

The Clinicians Speak, page-1014

  1. 1,570 Posts.
    lightbulb Created with Sketch. 547
    Hey Roughie

    Not a company Id be interested investing in and would prefer Polynovo kept well away from.
    Don't get me wrong.. I hope it succeeds, but I'm not convinced.
    I think its poorly managed and delivers massive losses. I Wouldn't put too faith in the management forecasts at the moment; Though they might prove me wrong.
    I'm also sus on the product itself. I think one needs to ask why the product cant get any market share in its home country (Australia) and why they were knocked back by the NHS in the UK..
    Fes
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.